(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.33%) $79.25
(-0.37%) $2.18
(-0.27%) $2 316.10
(-0.15%) $27.56
(-0.01%) $984.50
(0.03%) $0.930
(0.14%) $10.91
(0.03%) $0.800
(0.01%) $91.75
Live Chart Being Loaded With Signals
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages...
Stats | |
---|---|
本日の出来高 | 155 243 |
平均出来高 | 164 021 |
時価総額 | 298.13B |
EPS | INR0 ( 2024-05-01 ) |
次の収益日 | ( INR23.80 ) 2024-07-24 |
Last Dividend | INR15.00 ( 2023-08-04 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 40.63 |
ATR14 | INR1.712 (0.07%) |
ボリューム 相関
Ajanta Pharma Limited 相関
10 最も正の相関 | |
---|---|
BHARATWIRE.NS | 0.837 |
IZMO.NS | 0.823 |
ASHIANA.NS | 0.821 |
ASIANHOTNR.NS | 0.805 |
AUROPHARMA.NS | 0.801 |
GISOLUTION.NS | 0.801 |
10 最も負の相関 | |
---|---|
STARTECK.NS | -0.829 |
SEYAIND.NS | -0.806 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Ajanta Pharma Limited 相関 - 通貨/商品
Ajanta Pharma Limited 財務諸表
Annual | 2023 |
収益: | INR42.09B |
総利益: | INR21.06B (50.05 %) |
EPS: | INR64.82 |
FY | 2023 |
収益: | INR42.09B |
総利益: | INR21.06B (50.05 %) |
EPS: | INR64.82 |
FY | 2022 |
収益: | INR37.43B |
総利益: | INR26.92B (71.93 %) |
EPS: | INR45.89 |
FY | 2022 |
収益: | INR32.84B |
総利益: | INR23.97B (73.00 %) |
EPS: | INR54.97 |
Financial Reports:
No articles found.
Ajanta Pharma Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR7.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR15.00 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.133 | 2002-12-17 |
Last Dividend | INR15.00 | 2023-08-04 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | INR73.42 | -- |
Avg. Dividend % Per Year | 0.57% | -- |
Score | 3.23 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.25 | |
Div. Directional Score | 7.68 | -- |
Year | Amount | Yield |
---|---|---|
2002 | INR0 | 0.00% |
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR6.00 | 0.78% |
2019 | INR8.67 | 1.10% |
2020 | INR6.33 | 0.97% |
2021 | INR6.33 | 0.58% |
2022 | INR7.00 | 0.47% |
2023 | INR15.00 | 1.24% |
2024 | INR0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
TATACOFFEE.NS | Dividend Junior | 2023-05-15 | Annually | 23 | 0.85% | |
NIACL.NS | No Dividend Player | 2023-09-07 | Sporadic | 7 | 0.44% | |
INDIAGLYCO.NS | Dividend Junior | 2023-09-05 | Sporadic | 20 | 0.85% | |
CHOLAHLDNG.NS | Dividend Junior | 2023-08-03 | Annually | 23 | 0.06% | |
SANDHAR.NS | Dividend Junior | 2023-09-14 | Annually | 7 | 0.66% | |
LXCHEM.NS | Dividend Junior | 2023-07-20 | Annually | 4 | 0.11% | |
GLENMARK.NS | Dividend Junior | 2023-09-18 | Annually | 23 | 0.37% | |
ASIANPAINT.NS | Dividend Junior | 2023-06-09 | Semi-Annually | 23 | 0.43% | |
TINPLATE.NS | Dividend Junior | 2023-08-11 | Annually | 19 | 0.72% | |
PDMJEPAPER.NS | Dividend Junior | 2023-08-03 | Annually | 9 | 0.65% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.194 | 1.500 | 6.12 | 9.18 | [0 - 0.5] |
returnOnAssetsTTM | 0.176 | 1.200 | 4.13 | 4.96 | [0 - 0.3] |
returnOnEquityTTM | 0.235 | 1.500 | 8.51 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 3.05 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 1.944 | 0.800 | 3.27 | 2.62 | [0.8 - 2.5] |
cashRatioTTM | 0.146 | 1.500 | -0.300 | -0.450 | [0.2 - 2] |
debtRatioTTM | 0.00761 | -1.500 | 9.87 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 147.56 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 16.08 | 2.00 | 4.64 | 9.28 | [0 - 30] |
freeCashFlowPerShareTTM | 16.08 | 2.00 | 1.958 | 3.92 | [0 - 20] |
debtEquityRatioTTM | 0.00989 | -1.500 | 9.96 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.683 | 1.000 | 1.951 | 1.951 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.253 | 1.000 | 6.94 | 6.94 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 5.74 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.907 | 0.800 | 7.28 | 5.83 | [0.5 - 2] |
Total Score | 10.12 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 37.46 | 1.000 | 6.32 | 0 | [1 - 100] |
returnOnEquityTTM | 0.235 | 2.50 | 9.04 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 16.08 | 2.00 | 4.64 | 3.92 | [0 - 30] |
dividendYielPercentageTTM | 1.688 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 16.08 | 2.00 | 4.64 | 9.28 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.112 | 1.500 | 5.92 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0481 | 1.000 | -1.297 | 0 | [0.1 - 0.5] |
Total Score | 5.25 |
Ajanta Pharma Limited
Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye drops, cough syrups, etc. The company serves in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies, including armed forces, government hospitals, canteens, stores department, etc. The company was founded in 1973 and is headquartered in Mumbai, India.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。